Key research themes
1. What are the structural and mechanistic diversities of RNase A family enzymes and their evolutionary adaptations?
This research theme focuses on elucidating the structural organization, catalytic mechanisms, subunit composition, and evolutionary pathways of RNase A superfamily members, including RNA-dependent ribonucleases and protein-only RNase Ps (PRORPs). Understanding these characteristics is fundamental for deciphering the functional adaptations that underlie substrate recognition, catalysis, and the diversification of RNase A enzymes across different biological domains. Such insights are essential for appreciating RNase A's biological roles and evolutionary trajectories.
2. How do bacterial endoribonucleases RNase E and RNase P coordinate RNA processing and decay through substrate specificity and interaction with protein complexes?
This theme investigates the mechanistic roles of bacterial ribonucleases RNase E and RNase P in RNA metabolism, focusing on their substrate recognition, cleavage specificity, association with RNA chaperones and helicases, and assembly into multiprotein complexes such as degradosomes. It explores how these nucleases orchestrate processing of coding and non-coding RNAs, including small regulatory RNAs, thereby regulating gene expression, RNA quality control, and cellular responses. Deciphering these mechanisms advances knowledge of bacterial RNA turnover and regulatory networks.
3. What are the advances and challenges in applying antisense oligonucleotides and RNase-based technologies for therapeutic RNA targeting?
This research area addresses the development, mechanism of action, specificity, and off-target considerations of antisense oligonucleotides (ASOs) harnessing RNase H or related ribonucleases for targeted RNA cleavage. Investigations focus on elucidating factors influencing ASO design, target binding, and minimizing unintended transcript degradation, which are critical for enhancing therapeutic efficacy and safety. Moreover, studies also explore innovative use of RNase-based aptamers and RNA-protein interference mechanisms for gene regulation and drug development.